Lagoda Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-146
| Closed | -$55K | – | 28 |
|
|
2018
Q4 | $55K | Sell |
146
-57,285
| -100% | -$21.6M | 0.09% | 25 |
|
|
2018
Q3 | $23.2M | Sell |
57,431
-2,547
| -4% | -$1.03M | 9.7% | 2 |
|
|
2018
Q2 | $20.7M | Sell |
59,978
-6,682
| -10% | -$2.31M | 8.6% | 2 |
|
|
2018
Q1 | $23M | Buy |
66,660
+2,282
| +4% | +$786K | 8.66% | 2 |
|
|
2017
Q4 | $24.2M | Buy |
64,378
+8,661
| +16% | +$3.26M | 9.22% | 2 |
|
|
2017
Q3 | $24.9M | Buy |
55,717
+1,285
| +2% | +$575K | 9% | 2 |
|
|
2017
Q2 | $26.7M | Sell |
54,432
-14,701
| -21% | -$7.22M | 10.21% | 2 |
|
|
2017
Q1 | $26.8M | Sell |
69,133
-3,884
| -5% | -$1.51M | 10.4% | 2 |
|
|
2016
Q4 | $26.8M | Sell |
73,017
-114
| -0.2% | -$41.8K | 9.2% | 3 |
|
|
2016
Q3 | $29.4M | Buy |
73,131
+393
| +0.5% | +$158K | 8.84% | 2 |
|
|
2016
Q2 | $25.4M | Sell |
72,738
-1,578
| -2% | -$551K | 9.47% | 2 |
|
|
2016
Q1 | $26.8M | Sell |
74,316
-25,613
| -26% | -$9.23M | 8.77% | 2 |
|
|
2015
Q4 | $54.2M | Buy |
99,929
+181
| +0.2% | +$98.3K | 14.38% | 1 |
|
|
2015
Q3 | $46.4M | Sell |
99,748
-407
| -0.4% | -$189K | 13.54% | 1 |
|
|
2015
Q2 | $51.1M | Buy |
100,155
+4,666
| +5% | +$2.38M | 13.39% | 1 |
|
|
2015
Q1 | $43.1M | Buy |
95,489
+3,218
| +3% | +$1.45M | 11.53% | 1 |
|
|
2014
Q4 | $37.9M | Buy |
+92,271
| New | +$37.9M | 10.1% | 1 |
|